Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Atara Biotherapeutics, Inc. (ATRA) vs Pelthos Therapeutics Inc. (PTHS)

Atara Biotherapeutics, Inc. and Pelthos Therapeutics Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Pelthos Therapeutics Inc. are of similar size ($85.8M and $85.7M). Pelthos Therapeutics Inc. has the higher net margin (−199.5% vs −269.4%) and the lower return on invested capital (−82.3% vs 0.00%). Across the 15 metrics below, Pelthos Therapeutics Inc. leads on 9 and Atara Biotherapeutics, Inc. on 6.

Valuation

Metric ATRA PTHS Biotechnology median
P/E n/m n/m 7.88
P/S 21.38 1.82 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 19.79 2.92 10.73
Earnings yield (13.39%) (128.97%) (28.84%)
Free cash flow yield (15.88%) (54.04%) (23.03%)

Profitability

Metric ATRA PTHS Biotechnology median
Gross margin 91.38% 78.59% 65.16%
Operating margin (229.67%) (133.42%) 0.00%
Net margin (269.42%) (199.50%) 0.00%
Free cash flow margin (353.49%) (98.37%) 0.00%
Return on equity 46.33% 2,161.07% (57.72%)
Return on assets (57.62%) (125.04%) (49.22%)
Return on invested capital 0.00% (82.34%) 0.00%

Growth

Metric ATRA PTHS Biotechnology median
Revenue growth (TTM) (96.72%) — 5.64%
EPS growth (last fiscal year) 122.52% (61.12%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ATRA PTHS Biotechnology median
Debt to equity 0.00 (46.58) 0.00
Current ratio 1.98 1.98 4.73
Net debt to EBITDA (0.22) (0.45) 0.96

Dividend

Metric ATRA PTHS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric ATRA PTHS Biotechnology median
Market cap 85.72m 85.76m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack